rs80338939

Variant summary

Our verdict is Pathogenic. The variant received 6 ACMG points: 14P and 8B. BA1PS4PVS1PM3

This summary comes from the ClinGen Evidence Repository: The c.35delG variant in GJB2 is predicted to cause a premature stop codon in biologically-relevant-exon 2/2 that leads to a truncated or absent protein in a gene in which loss-of-function is an established mechanism (PVS1). This variant has been detected in patients with hearing loss in trans with at least 4 pathogenic or suspected-pathogenic variants (PM3_VS; PMID:26445815). This variant was found to have a statistically higher prevalence in affected individuals over controls (PS4; PMID:26969326, 25999548). The filtering allele frequency of the c.35delG variant in the GJB2 gene is 0.9% for European (Non-Finnish) chromosomes in the Genome Aggregation Database (1207/124552 with 95% CI), which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss variants (BA1). The ClinGen Hearing Loss Expert Panel believes that the evidence for the pathogenicity of this variant for hearing loss outweighs the high allele frequency of the variant in population databases. Therefore, the BA1 code will not contribute to the overall classification. In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive non-syndromic hearing loss based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PVS1, PM3_VS, PS4, BA1. LINK:https://erepo.genome.network/evrepo/ui/classification/CA127023/MONDO:0019497/005

Frequency

Genomes: 𝑓 0.0063 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0071 ( 34 hom. )

Consequence

GJB2
NM_004004.6 frameshift

Scores

Not classified

Clinical Significance

Pathogenic reviewed by expert panel P:99O:3

Conservation

PhyloP100: 7.85

Publications

860 publications found
Variant links:
Genes affected
GJB2 (HGNC:4284): (gap junction protein beta 2) This gene encodes a member of the gap junction protein family. The gap junctions were first characterized by electron microscopy as regionally specialized structures on plasma membranes of contacting adherent cells. These structures were shown to consist of cell-to-cell channels that facilitate the transfer of ions and small molecules between cells. The gap junction proteins, also known as connexins, purified from fractions of enriched gap junctions from different tissues differ. According to sequence similarities at the nucleotide and amino acid levels, the gap junction proteins are divided into two categories, alpha and beta. Mutations in this gene are responsible for as much as 50% of pre-lingual, recessive deafness. [provided by RefSeq, Oct 2008]
GJB2 Gene-Disease associations (from GenCC):
  • Bart-Pumphrey syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • ichthyosis, hystrix-like, with hearing loss
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp
  • keratoderma hereditarium mutilans
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, G2P
  • palmoplantar keratoderma-deafness syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • autosomal recessive nonsyndromic hearing loss 1A
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, PanelApp Australia
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • autosomal dominant keratitis-ichthyosis-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Genomics England PanelApp, Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss 3A
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • KID syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 6 ACMG points.

PVS1
For more information check the summary or visit ClinGen Evidence Repository.
PS4
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004004.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GJB2
NM_004004.6
MANE Select
c.35delGp.Gly12ValfsTer2
frameshift
Exon 2 of 2NP_003995.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GJB2
ENST00000382848.5
TSL:1 MANE Select
c.35delGp.Gly12ValfsTer2
frameshift
Exon 2 of 2ENSP00000372299.4
GJB2
ENST00000382844.2
TSL:6
c.35delGp.Gly12ValfsTer2
frameshift
Exon 1 of 1ENSP00000372295.1
GJB2
ENST00000906230.1
c.35delGp.Gly12ValfsTer2
frameshift
Exon 2 of 2ENSP00000576289.1

Frequencies

GnomAD3 genomes
AF:
0.00627
AC:
952
AN:
151764
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00124
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.00584
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.000194
Gnomad SAS
AF:
0.000833
Gnomad FIN
AF:
0.00956
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00980
Gnomad OTH
AF:
0.0106
GnomAD2 exomes
AF:
0.00597
AC:
1488
AN:
249362
AF XY:
0.00599
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00480
Gnomad ASJ exome
AF:
0.00318
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00808
Gnomad NFE exome
AF:
0.00920
Gnomad OTH exome
AF:
0.00718
GnomAD4 exome
AF:
0.00713
AC:
10423
AN:
1461600
Hom.:
34
Cov.:
32
AF XY:
0.00701
AC XY:
5100
AN XY:
727098
show subpopulations
African (AFR)
AF:
0.00128
AC:
43
AN:
33480
American (AMR)
AF:
0.00494
AC:
221
AN:
44692
Ashkenazi Jewish (ASJ)
AF:
0.00356
AC:
93
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000592
AC:
51
AN:
86208
European-Finnish (FIN)
AF:
0.00947
AC:
506
AN:
53412
Middle Eastern (MID)
AF:
0.00399
AC:
23
AN:
5764
European-Non Finnish (NFE)
AF:
0.00818
AC:
9092
AN:
1111824
Other (OTH)
AF:
0.00652
AC:
394
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
666
1332
1997
2663
3329
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
308
616
924
1232
1540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00627
AC:
952
AN:
151882
Hom.:
4
Cov.:
32
AF XY:
0.00601
AC XY:
446
AN XY:
74244
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41382
American (AMR)
AF:
0.00583
AC:
89
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5152
South Asian (SAS)
AF:
0.000833
AC:
4
AN:
4800
European-Finnish (FIN)
AF:
0.00956
AC:
101
AN:
10562
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00980
AC:
666
AN:
67938
Other (OTH)
AF:
0.0104
AC:
22
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
51
102
154
205
256
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00556
Hom.:
0
Bravo
AF:
0.00549
EpiCase
AF:
0.00916
EpiControl
AF:
0.00842

ClinVar

ClinVar submissions as Germline
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
38
-
-
Autosomal recessive nonsyndromic hearing loss 1A (39)
20
-
-
not provided (20)
7
-
-
Hearing impairment (7)
4
-
-
Autosomal dominant nonsyndromic hearing loss 3A (4)
4
-
-
GJB2-related disorder (4)
4
-
-
Hearing loss, autosomal recessive (5)
3
-
-
Autosomal dominant keratitis-ichthyosis-hearing loss syndrome;C0265964:Mutilating keratoderma;C0266004:Knuckle pads, deafness AND leukonychia syndrome;C1835672:Palmoplantar keratoderma-deafness syndrome;C1865234:Ichthyosis, hystrix-like, with hearing loss;C2673759:Autosomal recessive nonsyndromic hearing loss 1A;C2675750:Autosomal dominant nonsyndromic hearing loss 3A (4)
2
-
-
Knuckle pads, deafness AND leukonychia syndrome (2)
2
-
-
Nonsyndromic genetic hearing loss (2)
1
-
-
Autosomal recessive nonsyndromic hearing loss 104 (1)
1
-
-
Autosomal recessive nonsyndromic hearing loss 1A;C2675235:Autosomal recessive nonsyndromic hearing loss 1B (1)
1
-
-
Bilateral conductive hearing impairment;C1384666:Hearing impairment (1)
1
-
-
Bilateral sensorineural hearing impairment (1)
1
-
-
Bilateral sensorineural hearing impairment;C1384666:Hearing impairment (1)
1
-
-
Deafness (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
7.9
Mutation Taster
=5/195
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80338939; hg19: chr13-20763685; COSMIC: COSV101241530; COSMIC: COSV101241530; API